The J. Craig Venter Institute has appointed Karen Nelson as President and Robert Friedman as chief operating officer. They will report to Craig Venter, who will continue to lead JCVI as founder, CEO, and chairman of the board of trustees. Nelson has been at JCVI since 1996 and will continue to serve as director of the institute's offices in Rockville, Md., and leader of the Human Genomic Medicine Group. She will remain based in Rockville. Friedman has been with the institute since 2003 and he is director of the San Diego facility and head of the JCVI Policy Group. He will keep those duties but will take on more administrative leadership responsibilities.

XDx has named Peter Maag to be its president and CEO, effective immediately, the molecular diagnostics company said this week. Maag previously was president of Novartis Diagnostics, where he ran the company's blood screening business and created a strategy for the company's investment into developing diagnostics for transplantation, infectious disease, and prenatal care. He also was country president for Novartis Pharma in Germany and held other positions at Novartis after working at McKinsey and Company.

The Human Frontier Science Program Organization has awarded Stephen Quake the 2013 Nakasone Award for his work developing technologies in biophysics, biological automation, genome analysis, and personalized medicine. Quake is a professor of bioengineering and a Howard Hughes Medical Institute investigator at Stanford University. He is also a co-founder of Helicos Biosciences and Fluidigm.

Read this article:
Foundation Medicine, Eisai Ink Personalized Med Alliance

Comments are closed.